ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,867.08
-0.09%
Dow Jones
42,342.24
0.04%
US Dollar vs MXN
20.2888
-0.29%
Brent Oil
72.175
-0.29%
Bitcoin
97,153.28
-0.32%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE

  6. Immupharma Plc (IMM) Cotización

Immupharma Plc

Immupharma Plc (IMM)

Immutep Limited
International Metals Mining Corp
1.28
0.00
(0.00%)
Cerrado 20 Diciembre 10:30AM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
1.28
Postura de Compra
1.06
Postura de Venta
1.50
Volume Operado de la Acción
0.00
0.00 Rango del Día 0.00
0.83 Rango de 52 semanas 2.90
Capitalización de Mercado [m]
5.33M
Precio Anterior
1.28
Precio de Apertura
-
Hora
(O)
Última hora de negociación
-
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
1,385,282
Acciones en circulación
416,440,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-1.83
Beneficio por acción (BPA)
-0.01
turnover
-
Beneficio neto
-2.92M

Acerca de Immupharma Plc

Sector
Finance Services
Industria
Finance Diversified
Sitio web
www.immupharma.com
Sede
London, Gbr
Fundado
2006
Immupharma Plc is listed in the Finance Services sector of the London Stock Exchange with ticker IMM. The last closing price for Immupharma was 1.28p. Over the last year, Immupharma shares have traded in a share price range of 0.83p to 2.90p.

Immupharma currently has 416,440,000 shares in issue. The market capitalisation of Immupharma is £5.33 million. Immupharma has a price to earnings ratio (PE ratio) of -1.83.

IMM Últimas noticias

Más noticias

Immupharma PLC Holding(s) in Company

Immupharma PLC 10 December 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...

10 Diciembre 2024
RNS Regulatory News

Immupharma PLC Appointment of Company Secretary

Immupharma PLC 04 December 2024                                                                                                                                                                  ...

04 Diciembre 2024
RNS Regulatory News

ImmuPharma narrows losses in first half as expenses fall

ImmuPharma PLC on Monday expressed optimism about the potential of its pipeline, after narrowing pretax loss in the f ...

09 Septiembre 2024
Alliance News

ImmuPharma obtains second warrant extension with Incanthera

ImmuPharma PLC said on Monday it had extended its warrants in Incanthera PLC for the second time, valid now until Mar ...

09 Septiembre 2024
Alliance News

Immupharma PLC Extension of Warrants in Incanthera to 31 Mar 2025

Immupharma PLC 09 September 2024                                                                                                                                                                 ...

09 Septiembre 2024
RNS Regulatory News

Immupharma PLC Half-year Report

Immupharma PLC 09 September 2024   RNS: RELEASE | 9 September 2024       ImmuPharma PLC ("ImmuPharma" or the "Company")   INTERIM RESULTS for the six months ended 30 June 2024   ImmuPharma PLC...

09 Septiembre 2024
RNS Regulatory News

Immupharma PLC Holding(s) in Company

Immupharma PLC 06 August 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...

06 Agosto 2024
RNS Regulatory News

Immupharma PLC Result of AGM

Immupharma PLC 28 June 2024       RNS: RELEASE                                                                                                                                             ...

28 Junio 2024
RNS Regulatory News

EARNINGS AND TRADING: STV sees advertising upturn; Angle loss narrows

The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not s ...

05 Junio 2024
Alliance News

Immupharma PLC Notice of AGM & Annual Report & Accounts

Immupharma PLC 05 June 2024           RNS: RELEASE                                                                                                                                              ...

05 Junio 2024
RNS Regulatory News
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.010.7874015748031.271.3651.0212052541.21879379DE
4-0.295-18.73015873021.5751.6150.8523928731.19605656DE
12-0.53-29.28176795581.811.9950.8513852821.40620698DE
26-0.96-42.85714285712.242.30.8513166761.56136685DE
52-0.35-21.4723926381.632.90.8317252741.72993705DE
156-6.12-82.70270270277.49.50.8315970183.1647455DE
260-14.66-91.969887076515.9421.30.8313964125.76948887DE

IMM - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Immupharma?
El precio actual de las acciones de Immupharma es 1.28p
¿Cuántas acciones de Immupharma están en circulación?
Immupharma tiene 416,440,000 acciones en circulación
¿Cuál es la capitalización de mercado de Immupharma?
La capitalización de mercado de Immupharma es GBP 5.33M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Immupharma?
Immupharma ha negociado en un rango de 0.83p a 2.90p durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Immupharma?
El ratio precio/beneficio de Immupharma es -1.83
¿Cuál es la moneda de reporte de Immupharma?
Immupharma presenta sus resultados financieros en GBP
¿Cuál es el último beneficio anual de Immupharma?
El último beneficio anual de Immupharma es GBP -2.92M
¿Cuál es la dirección registrada de Immupharma?
La dirección registrada de Immupharma es ONE BARTHOLOMEW CLOSE, LONDON, EC1A 7BL
¿Cuál es la dirección del sitio web de Immupharma?
La dirección del sitio web de Immupharma es www.immupharma.com
¿En qué sector industrial opera Immupharma?
Immupharma opera en el sector FINANCE DIVERSIFIED

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
0A2IH World Group Ltd
US$ 0.00
(0.00%)
0
0A2DCrh Plc
US$ 0.00
(0.00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
US$ 0.00
(0.00%)
0
0A22Anheuser Busch Inbev Nv
US$ 0.00
(0.00%)
0
0A1UUber Technologies Inc
US$ 60.85
(0.00%)
1.06k
0A2IH World Group Ltd
US$ 0.00
(0.00%)
0
0A2DCrh Plc
US$ 0.00
(0.00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
US$ 0.00
(0.00%)
0
0A22Anheuser Busch Inbev Nv
US$ 0.00
(0.00%)
0
0A1UUber Technologies Inc
US$ 60.85
(0.00%)
1.06k
0R0XTesla Inc
US$ 437.40
(0.00%)
20.86k
0R24Intel Corp
US$ 19.45
(0.00%)
6.26k
0R1OAmazon.com Inc
US$ 225.50
(0.00%)
3.12k
0R2VApple Inc
US$ 251.50
(0.00%)
2.43k
0HCIAlibaba Group Holding Ltd
US$ 84.70
(0.00%)
2.32k

Discusión

Ver feed completo
IVRT IVRT 3 minutos hace
I think the last BMXI carrot is Hall Cadwick. There is no other reason to delay. Cannot replace Hall because the ladder does not go any higher up. The delays have become a millstone around BMXI's neck. Either as you say the audit is fictitious or the audit must be done in January. There are no
BMXI
chereb19 chereb19 18 minutos hace
Isopet has been proven to be profitable
RDGL
QuantumTravesty QuantumTravesty 21 minutos hace
Thanks.
HIRU
knrorrel knrorrel 37 minutos hace
very nice
QNCCF
GASMASK GASMASK 48 minutos hace
What's/who's TA?
MRGE
JerryCampbell JerryCampbell 1 hora hace
Data entry error the previous day.

Someone mistakenly entered 8,000,000 instead of 800,000. The -7.2m corrects it.
NWBO
georgejjl georgejjl 1 hora hace
I guess that Anavex could have sales of $14 billion during the first full year after approval in 2026 by the EMA in the EU alone based on capturing a 25% market share of the 8 million people in the EU with Alzheimer’s disease at a prescription cost of $7,000 per year per patient.

Go
AVXL
jeunke22 jeunke22 1 hora hace
Thanks KCC , I am still very positive about my investment here. Doing business implies to understand when it is time to adapt to a given set of circumstances. No need to try to go through a wall, if you can go around it. I think that is what has changed here. A more practical and energetic way to g
LWLG
DMC8 DMC8 1 hora hace
Feeling burnout recently fellow shareholders?

Watch the youtube chat on how to manage burnout by Patrice Bonfiglio, President of Sarissa Capital Management LP.
https://youtu.be/wpFutxLn-wk?si=6Rm2JhCbHvgvUcsb
AMRN
lodas lodas 1 hora hace
jhdf51........never buy a Put or a Call option unless you are 100% sure of the outcome at expiration.... why? you only a 50% chance of success... said another way... you either win, or lose...... however by Selling a Put, or Call options, you have a 66% chance of winning, or 2 ways out of three...
COOP
pepeoil pepeoil 1 hora hace
Good morning shrimpers. Bwahaaaaaa. We are broke. Lol
THEDOG 17 THEDOG 17 1 hora hace
O and you may as well clock out because Bio was acquired!! Yeah if you can’t figure it out maybe you should read that report eagle just posted!!!! Acquisition!!!!! Let’s gooo
jhdf51 jhdf51 1 hora hace
My bird in the hand is COOP. Escrow is now a ROC
capable of carrying hopeful escrowers in its talons.

JHD
COOP
jhdf51 jhdf51 1 hora hace
It seems that people playing options are like people going to Vegas.. they never lose.

JHD
COOP
2018trader 2018trader 1 hora hace
Just keep buying the monopoly 7, I mean mag 7
SPY
TCI1 TCI1 1 hora hace
I can’t open the link to the CVS coverage for 2025, would like to see it as they dropped Vascepa in July.

Sleven have you seen any positive or negative changes?
CVS
TCI1 TCI1 2 horas hace
Well UHC has both IPE and Vascepa covered with PA so you would hope and expect all CVD indications to go to Vascepa. Not sure if this is a change or not but by using a PA UHC are exposing themselves to litigation if they prioritise generic for CVD. Of course this is based off insurers adhering to th
AMRN
Real McCoy Real McCoy 2 horas hace
Yes. In this case the assets were acquired. A long time ago. Right?
THEDOG 17 THEDOG 17 2 horas hace
Sorry I can read !! Obviously you can’t. Acquisition-is that not a real word?
devil dog 96 devil dog 96 2 horas hace
Their O/S has been unchanged since 2021. These guys protect their share structure + they are great at marketing. Can't wait for them to be ready to fire up their next story. She is setup for some silver with how light they have kept her. Heck she has not had an RS since 2009 like 16 years ago and sh
CRSM
newmedman newmedman 2 horas hace
That's the GOP "man date" ;-)
go seek go seek 2 horas hace
Well, in this game one soon learns that the race is not a sprint. At least that’s my experience. We are all puzzled by the price drop since 24 October. We could debate the drop ad infinitum. I don’t understand it, and probably never will. GLTA
ENTA
Viewmont Viewmont 2 horas hace
It looks like we don't read the news or reports anymore.
They've been yelling that they're getting ready to submit it for FDA approval! LOL.
No need to do any DD, just rely on the next guy.

https://x.com/ADHCMANAGEMENT/status/1866858719339823271
https://x.com/ADH
ADHC
north40000 north40000 2 horas hace
Am I correct that all LTCLs and STCLs currently can be used by either spouse to offset any corresponding LTCGs and STCGs accruing in taxable account(s) in any year before death of either spouse?
AMRN

Su Consulta Reciente

LSE
IMM
Immupharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados